Danaher investor day could bring relief rally, says JPMorgan JPMorgan thinks shares of Danaher could see a relief rally into and around the company's investor day on December 12. The firm thinks consensus growth expectations for 2013 do not need to come down and keeps an Overweight rating on the stock with a $59 price target.
News For DHR From The Last 14 Days
Check below for free stories on DHR the last two weeks.
Hologic seen as takeover target after Icahn takes stake, Bloomberg says Carl Icahn's intent in taking a 12.6% stake in Hologic (HOLX) is likely a sale of the company, according to Bloomberg's "Real M&A" column. Analysts at Cantor Fitzgerald said Hologic could appeal to conglomerates like Siemens (SI) or Danaher (DHR) or to a consortium of private-equity and strategic bidders, the report noted. Reference Link